UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000058856
Receipt number R000067297
Scientific Title Early Mobilization Practices in Critically Ill Children in Japan: A One-day Point-Prevalence Study
Date of disclosure of the study information 2025/09/01
Last modified on 2025/08/21 12:33:15

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Early Mobilization Practices in Critically Ill Children in Japan: A One-day Point-Prevalence Study

Acronym

EMJ PoP-p study

Scientific Title

Early Mobilization Practices in Critically Ill Children in Japan: A One-day Point-Prevalence Study

Scientific Title:Acronym

EMJ PoP-p study

Region

Japan


Condition

Condition

Pediatric patients admitted to ICUs on a designated study day

Classification by specialty

Pediatrics Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

1) To clarify the implementation rate of early rehabilitation in critically ill pediatric patients admitted to intensive care units in Japan, including PICUs.

Basic objectives2

Others

Basic objectives -Others

2) To investigate the assessments performed and the content of rehabilitation provided.
3) To investigate the barriers to rehabilitation based on patient information in cases where rehabilitation could not be implemented.

Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Presence or absence of rehabilitation.

Key secondary outcomes

Intensive Care Unit Mobility Scale (IMS):
For each patient, the level of activity on the designated study day will be evaluated using the IMS (a description of the scale will be attached in the data entry sheet).
Even in cases where basic activities such as independent sitting are difficult, or in infants/toddlers with unstable gait, evaluation will still be conducted using the IMS; however, during analysis, these cases may be excluded or subjected to subgroup analyses depending on the number of such patients.
If the patient performed in-bed exercises, information will be collected regarding the specific type of activity, including range of motion exercises, positioning, respiratory physiotherapy, developmental support, strength training, neuromuscular electrical stimulation (NMES), or in-bed cycle ergometer training.
In addition, information on the presence or absence of adverse events during rehabilitation will also be collected.

Barriers to Rehabilitation:
Barriers to the implementation of rehabilitation will be identified and recorded.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

1 months-old <

Age-upper limit

15 years-old >=

Gender

Male and Female

Key inclusion criteria

Pediatric patients admitted to ICUs at each participating facility on a designated study day will be included as study subjects.
Pediatric patients are defined as those aged 0 to 15 years.

Key exclusion criteria

Patients who were admitted to the ICU for reasons such as bed control, and who would not normally require ICU admission, will be excluded.
For example, patients scheduled to be discharged from the ICU within 24 hours.

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Saori
Middle name
Last name Miyagishima

Organization

Japan Healthcare University

Division name

Faculty of Health Sciences

Zip code

062-0053

Address

1-50, Tsukisamu Higashi 3-jo 11-chome, Toyohira-ku, Sapporo-shi, Hokkaido

TEL

011-351-6100

Email

s-miyagishima@jhu.ac.jp


Public contact

Name of contact person

1st name Saori
Middle name
Last name Miyagishima

Organization

Japan Healthcare University

Division name

Faculty of Health Sciences

Zip code

062-0053

Address

1-50, Tsukisamu Higashi 3-jo 11-chome, Toyohira-ku, Sapporo-shi, Hokkaido

TEL

011-351-6100

Homepage URL


Email

s-miyagishima@jhu.ac.jp


Sponsor or person

Institute

Japan Healthcare University

Institute

Department

Personal name

Saori Miyagishima


Funding Source

Organization

Japan Healthcare University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Japan Healthcare University

Address

1-50, Tsukisamu Higashi 3-jo 11-chome, Toyohira-ku, Sapporo-shi, Hokkaido

Tel

011-351-6100

Email

rinri@jhu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 09 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

200

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2025 Year 03 Month 15 Day

Date of IRB

2024 Year 12 Month 10 Day

Anticipated trial start date

2025 Year 08 Month 10 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry

2026 Year 03 Month 31 Day

Date trial data considered complete


Date analysis concluded



Other

Other related information

Retrospective registration, multicenter study, ethics approval obtained.


Management information

Registered date

2025 Year 08 Month 21 Day

Last modified on

2025 Year 08 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067297